Stability of Ampicillin plus Ceftriaxone Combined in Elastomeric Infusion Devices for Outpatient Parenteral Antimicrobial Therapy

• Main Authors: Beatriz Fernández-Rubio (Author), Laura Herrera-Hidalgo (Author), Rafael Luque-Márquez (Author), Arístides de Alarcón (Author), Luis E. López-Cortés (Author), Sonia Luque-Pardos (Author), José María Gutiérrez-Urbón (Author), Aurora Fernández-Polo (Author), María V. Gil-Navarro (Author), Alicia Gutiérrez-Valencia (Author)
• Format: Book
• Published: MDPI AG, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.3390/antibiotics12030432; 2079-6382
• Keywords: stability; outpatient parenteral antimicrobial therapy; elastomers; ampicillin; ceftriaxone; infective endocarditis; Therapeutics. Pharmacology; RM1-950
• Source: Antibiotics, Vol 12, Iss 3, p 432 (2023)

Currently, ampicillin plus ceftriaxone (AC) is one of the preferred treatments for <i>Enterococcus faecalis</i> infective endocarditis. However, there is a lack of stability data for the combination of both drugs in elastomeric devices, so the inclusion of AC in Outpatient Parenteral Antimicrobial Therapy (OPAT) programs is challenging. The objective of the study was to determine the stability of AC in elastomeric pumps when stored at 8 ± 2 °C, 25 ± 2 °C, 30 ± 2 °C and 37 ± 2 °C using LC-MS/MS. The combination was diluted in 0.9% sodium chloride and the final concentrations were ampicillin 24 g/L plus ceftriaxone 8 g/L. Physical and chemical stability were evaluated at 12, 20, 24, 36 and 48 h after preparation. Stability was met at each time point if the percentage of intact drug was ≥90% of its respective baseline concentration and color and clearness remained unchanged. The drug combination was stable for 48 h when it was kept at 8 ± 2 °C. At 25 ± 2 °C and 30 ± 2 °C, they were stable for 24 h of storage. At 37 ± 2 °C, the stability criterion was not met at any time point. These results prove that AC could be included in OPAT programs using elastomeric infusion devices for the treatment of <i>E. faecalis</i> infections.